Background: Enteric fever is a major public health problem in Nepal. Trends of drug resistance help in choosing optimal empiric therapy. Objective: The objective of this study was to determine antibiotic resistance pattern of Salmonella enterica serotype typhi and Salmonella enterica serotype paratyphi isolated from blood cultures. Methodology: A descriptive study was conducted using hospital records at KIST Medical College and Teaching Hospital, Nepal. Isolates from blood cultures between January 2011 and December 2013 were included in this study. Susceptibility to various antimicrobials was determined using modifi ed Kirby-Bauer disk diffusion method. A chi-square for trend analysis was done to evaluate change in susceptibility over three years. Results: Out of 216 isolates, 68.05% were Salmonella typhi and 31.48% were Salmonella paratyphi A. In Salmonella typhi, there was signifi cant increase in cefotaxime resistance(X 2 = 4.951, p < 0.05) and ciprofl oxacin resistance (X 2 = 17.506, p < 0.001) whereas there was signifi cant decrease in ampicillin resistance (X 2 = 4.830, p < 0.05). No resistance was seen against ceftriaxone in Salmonella typhi and Salmonella paratyphi A. Resistance to chloramphenicol and cotrimoxazole was low as well, in both isolates. None of the isolates tested were multidrug resistant. Conclusion: There is emergence of resistance to cefotaxime whereas resistance to ciprofl oxacin has made its use as empiric therapy questionable. Full susceptibility of ceftriaxone makes it an excellent antibiotic for empiric therapy. Decrease in resistance to chloramphenicol, cotrimoxazole and ampicillin may again make these agents useful.
. In 1973, its resistance became a global problem 8 . Towards the late 1980s and 1990s, multidrug resistant strains emerged 8 . Multidrug resistance (MDR) is defi ned as simultaneous resistance to drugs chloramphenicol, ampicillin and cotrimoxazole. Due to the multidrug resistance fl uoroquinolones such as ciprofl oxacin became the drug of choice for treating enteric fever 9, 10 . Several publications have appeared in last decade documenting decreased susceptibility to fl uoroquinolones 11 . Understanding of the drug resistance trend helps in choosing the optimal empirical treatment. Thus we conducted a cross-sectional study to understand the antimicrobial resistance pattern in ST and SPA.
INTRODUCTION
S almonella enterica serotype typhi (ST) cause typhoid fever whereas Salmonella enterica serotype paratyphi A (SPA), B (SPB) and C cause paratyphoid fever. Global estimate showed a total of 26.9 million episodes of typhoid fever in 2010, which is comparable to the global estimate in 2000 1, 2 .
Enteric fever is a major public health problem in Nepal with most cases seen during the monsoon period 3 . In recent years, studies have shown increase in incidence of SPA infection 4, 5 
RESULTS
A total of 216 isolates of ST, SPA and SPB were obtained. Among them, 68.05% were ST and 31.48% were SPA. Only a single isolate of SPB was obtained over 3 years. Enteric fever was found to be more common in age group 10-19 years (32.9%) followed by age group 20-29 years (31.5%) and age group 0-9 years (16.7%)(Table1). Males were more commonly affected than females with 54.4% of ST infection and 66.2% of SPA infection occurring in males. Table 2 shows the resistance pattern of ST to various antimicrobials. Increase in resistance to ciprofl oxacin and cefotaxime was observed in ST isolates. In 2013, there was a sudden rise in ciprofl oxacin resistance (27.7%, n = 65) and cefotaxime resistance (9.4%, n= 64). Simultaneous resistance to both ciprofl oxacin and cefotaxime were observed in 2 isolates. In contrast, we found gradual decrease in ampicillin resistance over three years. No resistance was noted against ceftriaxone and gentamicin. Resistance to cotrimoxazole (13.3%, n = 15) and chloramphenicol (13.3%, n = 15) was low and was only seen in year 2012. Table 3 shows the resistance pattern of SPA to various antimicrobials. SPA isolates were fully susceptible to antibiotics ceftriaxone, ciprofl oxacin, chloramphenicol and gentamicin. Resistance to ampicillin was seen in 2011 (28.6%, n = 28) and 2012 (50%, n =14). SPA isolates were resistant to cotrimoxazole in 2011 (4.8%, n =21) only (Table 3) . None of the isolates of ST and SPA were multi drug resistant.
Chi square for trend analysis in ST showed linear by linear trends in cefotaxime resistance (X 2 = 4.951, p < 0.05), ciprofl oxacin resistance (X 2 = 17.506, p < 0.001) and ampicillin resistance (X 2 = 4.830, p < 0.05) ( Table 2 ). Linear by linear association of antimicrobial resistance was not seen in SPA (Table 3) . 
DISCUSSION
Despite increase in incidence of SPA infection 4 and studies reporting more than 50% of isolates being SPA 12,13 , we found only 31.48% of the isolates being SPA. Most of the isolates were ST. Enteric fever caused by SPB is rare. Only a single isolate of SPB was obtained in three years. Enteric fever was most commonly seen in age group 10 -29 years (Table 1) . This may be due to high likelihood of this age group to drink unpurifi ed water. The main goal of this research was to determine the resistance of Salmonella enterica serotypes against various antimicrobials.
CIPROFLOXACIN
Our study suggests that there is a signifi cant rise in ciprofl oxacin resistance (p < 0.001) in ST. None of the isolates tested in 2011 and 2012 were resistant to ciprofl oxacin. However, in 2013, 27.7% (n=65) of the isolates of ST were resistant to ciprofl oxacin. In contrast, SPA isolates were sensitive to ciprofl oxacin throughout the three years. Increase in ciprofl oxacin resistance has also been reported from other studies in Nepal 11, [14] [15] [16] .
Ciprofl oxacin is used as an empiric therapy for enteric fever. Our fi ndings indicate that ciprofl oxacin may not be effective in enteric fever. Decrease in sensitivity may be due to overuse of fl uoroquinolones and their availability without a prescription in Nepal.
CEFTRIAXONE
No resistance was seen against ceftriaxone in three years. This demonstrates that ST and SPA are fully susceptible to ceftriaxone. These results are consistent with other studies from Nepal which have shown full susceptibility to ceftriaxone [14] [15] [16] . An important implication of these fi ndings is that ceftriaxone is a very good choice for empirical treatment of suspected enteric fever. However, decreased susceptibility has been reported 5 .
CEFOTAXIME
In contrast to ceftriaxone, which is fully susceptible, resistance to cefotaxime is gradually increasing. An ordered increase in the resistance rate to cefotaxime was observed in ST with 0% (n =43) in 2011, and 9.4% (n=64) in 2013 (p = 0.026). Cefotaxime resistant SPA . Unfortunately, it did not mention the number or percentage of isolates resistant to cefotaxime. However, the resistant isolates were found to be extended spectrum beta-lactamase (ESBL) test positive. Moderate susceptibility to cefotaxime (not resistance) has been reported by Pokharel et al. 13 . They found three isolates of ESBL producing SPA. In contrast to these studies, full susceptibility of isolates to cefotaxime has been documented by Shrestha et al. 16 . As ESBL gene is mobile in nature, the mechanism of resistance in ST and SPA may be due to horizontal transfer of ESBL gene. Future studies should look for presence of ESBL gene if cefotaxime resistant ST or SPA is isolated.
CHLORAMPHENICOL, COTRIMOXAZOLE, AMPICILLIN
Our study indicates that there has been a signifi cant decrease in ampicillin resistance in ST (p = 0.028). Resistance to cotrimoxazole (13.3%, n = 15) and chloramphenicol (13.3%, n=15) was low as well and seen only in 2012.
In SPA isolates, no resistance was observed against chloramphenicol. However, ampicillin resistance was seen in 2011 (28.6%, n = 28) and 2012 (50%, n =14). Cotrimoxazole resistance was seen only in 2011 (4.8%, n =21).
Decrease in resistance in ST and SPA may be due to decrease in use of these traditional fi rst line antimicrobials. A signifi cant decrease in resistance to chloramphenicol and cotrimoxazole has also been reported from Nepal 11, 16, 18 . Decrease in resistance may again make these antibiotics useful in near future.
None of the isolates tested were MDR, which is defi ned as simultaneous resistance to chloramphenicol, ampicillin and cotrimoxazole. This shows that MDR strains are decreasing. This fi nding is consistent with decreasing trend of MDR strains in Nepal 11 . Decrease in MDR may again be attributed to decrease in use of traditional fi rst line drugs.
GENTAMICIN
No resistance was seen against gentamicin. Other studies have also reported similar fi nding 14, 15 . However, because of toxicity its use is limited.
There were some limitations of our study. Minimal inhibitory concentrations of the antibiotics were not determined. Isolates were not tested against nalidixic acid, which is considered as a maker for decreased sensitivity to fl uoroquinolones 19 . As this study was conducted using hospital records, not all the isolates were tested against all the antibiotics used for this study.
CONCLUSIONS
In conclusion, there is emergence of resistance tocefotaxime. Signifi cant resistance to ciprofl oxacin makes its use questionable as an empiric therapy. However, ceftriaxone is fully susceptible which makes it a useful empirical antibiotic. Decrease in resistance to chloramphenicol, cotrimoxazole and ampicillin may again make these agents a therapeutic option.
